Rambam Stanford Collaboration Dinner
On June 6, in Stanford, California, American Friends of Rambam supporters, Miki and David Donoho, graciously hosted a kick-off dinner to celebrate the Stanford Medicine and Rambam Healthcare Campus multifaceted health sciences collaboration. The evening focused on launching Stanford’s world-renowned programs in innovation including Biodesign and SPARK Global at Rambam. Guest speakers included Prof. Rafi Beyar, the former CEO of Rambam, as well as Stanford Medicne’s key medical leadership Dr. Eben Rosenthal, Dr. Richard Popp, Dr. Daria Mochly Rosen, and Dr. Yona Vaisbuch.
The combination of superb health care delivery, engineering-oriented research and innovations, and training future leaders in medicine and biotech, are qualities common to both Rambam and Stanford Medicine and are central to the collaboration.
The goal of this collaboration is to facilitate interaction and exchange of ideas and resources to benefit discovery and human health. Rambam expects to expand research ties, engage in mutual exchanges of physicians, staff and students in order to enrich the clinical, scientific, research and educational environment of both institutions.
Key priorities of the collaboration include:
- Innovations in Health Care: developing educational programs to promote innovations in medical technologies and drug discovery. Stanford will leverage existing programs to accelerate innovation at Rambam.
- Mass Trauma Organization: working together on programs to improve the treatment of trauma victims, enhance trauma treatment organizational systems, and more effectively utilize technology.
- Digital Health and Big Data: sharing big data analysis and approaches to machine learning using existing datasets available within the Rambam Medical Center.
- Cancer Management: exchanging oncologists and administrators to collaborate on development of effective care delivery systems that put patients first and promote high-quality care.
- Cardiovascular Stem Cell Research: collaborating on cardiovascular stem cell-based research, including genetically based personalized approaches for treatment of adult cardiovascular patients and children with genetic arrhythmogenic disorders.
In featured image above (L to R): Oren Dobronsky, Prof. Rafi Beyar, Dr. Yona Vaisbuch, Dr. Levy Gerzberg and Dr. Richard Popp.